Lung and pleura

doi:10.1017/CBO9781139026543.009

Chapter 7 - Lung and pleura

from Part II - Oncologic applications

Published online by Cambridge University Press: 05 September 2012

Victor H. Gerbaudo

Edited by

Victor H. Gerbaudo

Show author details

Victor H. Gerbaudo: Affiliation:
Brigham and Women's Hospital, Harvard Medical School

Book contents

Get access

Summary

Lung cancer

In 2011 the total number of expected cancer cases in the USA is 1,596,670 with 571,950 estimated deaths from cancer. The expected number of new lung cancer cases is 221,130 (115,060 men and 106,070 women), of which a total of 156,940 are expected to die from the disease (85,600 men and 71,340 women) (1). These data place lung cancer as the second most commonly diagnosed malignancy, and as the leading cause of cancer-related deaths in both men and women in the USA (1).

Amongst the known risk factors for developing lung cancer, cigarette smoking occupies the first place in importance (more than 90% of cases), followed by occupational and environmental exposure to adon, asbestos, second-hand smoke, chromium, arsenic, cadmium, organic chemicals, air pollution, radiation, and a previous history of tuberculosis. In those that develop lung cancer at a younger age, genetic susceptibility is also considered an important contributing risk factor (1).

Histology

The tumor cell type and the stage at presentation affect the prognosis and survival after treating lung cancer patients. Accurate diagnosis with confirmed cell type is of utmost importance. Lung cancers are divided into two main histologic types: non-small cell lung cancer (NSCLC) and small-cell lung cancer (SCLC). The histologic classification of lung cancer has undergone several revisions since the original 1967 recommendation proposed by the World Health Organization (WHO). The most significant update took place in 1999, followed by a slight change in 2004 (2–5). The revised cellular classification for NSCLC and SCLC summarizing the 1999 and 2004 WHO recommendations is presented in Table 7.1.

Type: Chapter
Information: A Case-Based Approach to PET/CT in Oncology , pp. 128 - 173

DOI: https://doi.org/10.1017/CBO9781139026543.009 [Opens in a new window]

Publisher: Cambridge University Press

Print publication year: 2012

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Siegel, RWard, EBrawley, DJemal, A.Cancer Statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deathsCA Cancer J Clin 2011 61 212CrossRef Google Scholar PubMed

Travis, WDColby, TVCorrin, BShimosato, YBrambilla, E.Collaboration with Sobin LH and Pathologists from 14 Countries. World Health Organization International Histological Classification of TumoursHistological Typing of Lung and Pleural TumoursBerlinSpringer-Verlag 1999CrossRef Google Scholar

Travis, WDBrambilla, EMuller-Hermelink, HKHarris, CCWorld Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Lung, Pleura, Thymus and HeartLyonIARC Press 2004Google Scholar

Travis, WDGarg, KFranklin, WAEvolving concepts in the pathology and computed tomography imaging of lung adenocarcinoma and bronchioloalveolar carcinomaJ Clin Oncol 2005 23 3279CrossRef Google Scholar PubMed

Travis, WDGarg, KFranklin, WABronchioloalveolar carcinoma and lung adenocarcinoma: the clinical importance and research relevance of the 2004 World Health Organization pathologic criteriaJ Thorac Oncol 2006 1 S13CrossRef Google Scholar PubMed

Travis, WDBrambilla, EInternational Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung AdenocarcinomaJ Thorac Oncol 2011 6 244CrossRef Google Scholar

Hirsch, FRMatthews, MJAisner, SHistopathologic classification of small cell lung cancer. Changing concepts and terminologyCancer 1988 62 9733.0.CO;2-O>CrossRef Google Scholar PubMed

Edge, SBByrd, DRCompton, CCAJCC Cancer Staging ManualNew York, NYSpringer 2010 253Google Scholar PubMed

Godlstraw, PCrowley, JChanskey, KThe IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumoursJ Thorac Oncol 2007 2 706Google Scholar

Quekel, LGKessels, AGGoei, Rvan Engelshoven, JM.Miss rate of lung cancer on the chest radiograph in clinical practiceChest 1999 115 720CrossRef Google Scholar PubMed

Silvestri, GAGould, MKMargolis, MLNoninvasive staging of non-small cell lung cancer: ACCP evidenced-based clinical practice guidelinesChest 2007 132 178SCrossRef Google Scholar PubMed

Yung, RC.Tissue diagnosis of suspected lung cancer: selecting between bronchoscopy, transthoracic needle aspiration, and resectional biopsyRespir Care Clin N Am 2003 9 51CrossRef Google Scholar PubMed

Lacasse, YWong, EGuyatt, GHCook, DJ.Transthoracic needle aspiration biopsy for the diagnosis of localised pulmonary lesions: a meta-analysisThorax 1999 54 884CrossRef Google Scholar

De Leyn, PLerut, T.Cervical mediastinoscopyMultimedia Manual of Cardiothoracic Surgery 2005 http://mmcts.ctsnetjournals.org/cgi/reprint/2005/0324/mmcts.2004.000158.pdfGoogle Scholar

De Leyn, PVansteenkiste, JCuypers, PRole of cervical mediastinoscopy in staging of non-small cell lung cancer without enlarged mediastinal lymph nodes on CT scanEur J Cardiothorac Surg 1997 12 706CrossRef Google Scholar PubMed

De Leyn, PStroobants, SDe Wever, WProspective comparative study of integrated positron emission tomography-computed tomography scan compared with remediastinoscopy in the assessment of residual mediastinal lymph node disease after induction chemotherapy for mediastinoscopy-proven stage IIIA-N2 Non-small-cell lung cancer: a Leuven Lung Cancer Group StudyJ Clin Oncol 2006 24 3333CrossRef Google Scholar PubMed

Harris, RJKavuru, MSRice, TWKirby, KJ.The diagnostic and therapeutic utility of thoracoscopyChest 1995 108 828CrossRef Google Scholar PubMed

Landreneau, RJMack, MJHazelrigg, SRVideo assisted thoracic surgery: basic technical concepts and intercostal approach strategiesAnn Thorac Surg 1992 54 800CrossRef Google Scholar PubMed

National Comprehensive Cancer Networkhttp://www.nccn.org/professionals/physician_gls/f_guidelines.asp 2010

Jackman, DMJohnson, BE.Small-cell lung cancerLancet 2005 366 1385CrossRef Google Scholar PubMed

Simon, GRTurrisi, AAmerican College of Chest Physicians. Management of small cell lung cancer: ACCP evidence-based clinical practice guidelinesChest 2007 132 324SCrossRef Google Scholar PubMed

Lillington, GA.Management of solitary pulmonary nodulesDis Mon 1991 37 271CrossRef Google Scholar PubMed

Khouri, NFMeziane, MAZerhouni, EAFishman, EK.The solitary pulmonary nodule: assessment, diagnosis, and managementChest 1987 91 128CrossRef Google Scholar

Ost, DFein, AMFeinsilver, SH.Clinical practice: the solitary pulmonary noduleN Engl J Med 2003 348 2535CrossRef Google Scholar PubMed

Swensen, SJJett, JRPayne, WSAn integrated approach to evaluation of the solitary pulmonary noduleMayo Clin Proc 1990 65 173CrossRef Google Scholar PubMed

Gould, MKFletcher, JIannettoni, MDAmerican College of Chest Physicians. Evaluation of patients with pulmonary nodules: when is it lung cancer?: ACCP evidence-based clinical practice guidelinesChest 2007 132 108SCrossRef Google Scholar PubMed

Swensen, SJSilverstein, MDIlstrup, DMSchleck, CDEdell, ES.The probability of malignancy in solitary pulmonary nodules. Application to small radiologically indeterminate nodulesArch Intern Med 1997 157 849CrossRef Google Scholar PubMed

Swensen, SJViggiano, RWMidthun, DELung nodule enhancement at CT: multicenter studyRadiology 2000 214 73CrossRef Google Scholar PubMed

Gurney, JW.Determining the likelihood of malignancy in solitary pulmonary nodules with Bayesian analysis. Part I. TheoryRadiology 1993 186 405CrossRef Google Scholar PubMed

Zerhouni, EAStitik, FPSiegelman, SSCT of the pulmonary nodule: a cooperative studyRadiology 1986 160 319CrossRef Google Scholar PubMed

Henschke, CIYankelevitz, DFMirtcheva, RELCAP Group. CT screening for lung cancer: frequency and significance of part-solid and nonsolid nodulesAm J Roentgenol 2002 178 1053CrossRef Google Scholar PubMed

Woodring, JHFried, AM.Significance of wall thickness in solitary cavities of the lung: a follow-up studyAm J Roentgenol 1983 140 473CrossRef Google Scholar PubMed

Yankelevitz, DFHenschke, CI.Does 2-year stability imply that pulmonary nodules are benign?Am J Roentgenol 1997 168 325CrossRef Google Scholar PubMed

Erasmus, JJMcAdams, HPConnolly, JE.Solitary pulmonary nodules: Part II. Evaluation of the indeterminate noduleRadiographics 2000 20 59CrossRef Google Scholar PubMed

Gupta, NCMaloof, JGunel, E.Probability of malignancy in solitary pulmonary nodules using fluorine-18-FDG and PETJ Nucl Med 1996 37 943Google Scholar PubMed

Lowe, VJFletcher, JWGobar, LProspective investigation of PET in lung nodules (PIOPILN)J Clin Oncol 1998 16 1075CrossRef Google Scholar

Gould, MKMaclean, CCKuschner, WGRydzak, CEOwens, DK.Accuracy of positron emission tomography for diagnosis of pulmonary nodules and mass lesions: a meta-analysisJ Am Med Assoc 2001 285 914CrossRef Google Scholar PubMed

Kim, YHLee, KSPrimack, SLSmall pulmonary nodules on CT accompanying surgically resectable lung cancer: likelihood of malignancyJ Thorac Imaging 2002 17 40CrossRef Google Scholar PubMed

Chalmers, NBest, JJ.The significance of pulmonary nodules detected by CT but not by chest radiography in tumor stagingClin Radiol 1991 44 410CrossRef Google Scholar PubMed

Yuan, YMatsumoto, THiyama, AThe probability of malignancy in small pulmonary nodules coexisting with potentially operable lung cancer detected by CTEur Radiol 2003 13 2447CrossRef Google Scholar PubMed

Herder, GJGolding, RPHoekstra, OSThe performance of (18)F-fluorodeoxyglucose positron emission tomography in small solitary pulmonary nodulesEur J Nucl Med Mol Imaging 2004 31 1231CrossRef Google Scholar PubMed

Divisi, DDi Tommaso, SDi Leonardo, G18-fluorine fluorodeoxyglucose positron emission tomography with computerized tomography versus computerized tomography alone for the management of solitary lung nodules with diameters inferior to 1.5 cmThorac Cardiovasc Surg 2010 58 422CrossRef Google Scholar PubMed

Higashi, KUeda, YSeki, HFluorine-18-FDG PET imaging is negative in bronchioloalveolar lung carcinomaJ Nucl Med 1998 39 1016Google Scholar PubMed

Erasmus, JJMcAdams, HPPatz, EFEvaluation of primary pulmonary carcinoid tumors using FDG PETAm J Roentgenol 1998 170 1369CrossRef Google Scholar PubMed

Bryant, ASCerfolio, RJ.The maximum standardized uptake values on integrated FDG-PET/CT is useful in differentiating benign from malignant pulmonary nodulesAnn Thorac Surg 2006 82 1016CrossRef Google Scholar PubMed

O JHYoo IeRKim, SHSohn, HSChung, SK.Clinical significance of small pulmonary nodules with little or no 18F-FDG uptake on PET/CT images of patients with nonthoracic malignanciesJ Nucl Med 2007 48 15Google Scholar

Matthies, AHickeson, MCuchiara, AAlavi, A.Dual time point 18F-FDG PET for the evaluation of pulmonary nodulesJ Nucl Med 2002 43 871Google Scholar PubMed

Cloran, FJBanks, KPSong, WSKim, YBradley, YC.Limitations of dual time point PET in the assessment of lung nodules with low FDG avidityLung Cancer 2010 68 66CrossRef Google Scholar PubMed

Erdi, YENehmeh, SAPan, TThe CT motion quantitation of lung lesions and its impact on PET measured SUVsJ Nucl Med 2004 45 1287Google Scholar PubMed

Park, SJIonascu, DKilloran, JEvaluation of the combined effects of target size, respiratory motion and background activity on 3D and 4D PET/CT imagesPhys Med Biol 2008 3661CrossRef Google Scholar PubMed

Werner, MKParker, JAKolodny, GMEnglish, JRPalmer, MR.Respiratory gating enhances imaging of pulmonary nodules and measurement of tracer uptake in FDG PET/CTAm J Roentgenol 2009 193 1640CrossRef Google Scholar PubMed

Jones, HAClark, RJRhodes, CGPositron emission tomography of 18FDG uptake in localized pulmonary inflammationActa Radiol Suppl 1991 376Google Scholar PubMed

Chang, JMLee, HJGoo, JMFalse positive and false negative FDG-PET scans in various thoracic diseasesKorean J Radiol 2006 7 57CrossRef Google Scholar PubMed

Alavi, AGupta, NAlberini, JLPositron emission tomography imaging in nonmalignant thoracic disordersSemin Nucl Med 2002 32 293CrossRef Google Scholar PubMed

Gerbaudo, VHJulius, B.Anatomo-metabolic characteristics of atelectasis in F-18 FDG-PET/CT imagingEur J Radiol 2007 64 401CrossRef Google Scholar PubMed

Britz-Cunningham, SHMillstine, JWGerbaudo, VH.Improved discrimination of benign and malignant lesions on FDG PET/CT, using comparative activity ratios to brain, basal ganglia, or cerebellumClin Nucl Med 2008 33 681CrossRef Google Scholar PubMed

Lardinois, DWeder, WHany, TFStaging of non–small-cell lung cancer with integrated positron emission tomography and computed tomographyN Engl J Med 2003 348 2500CrossRef Google Scholar PubMed

Kim, SKAllen-Auerbach, MGoldin, JAccuracy of PET/CT in characterization of solitary pulmonary lesionsJ Nucl Med 2007 48 214Google Scholar PubMed

Yamashita, KMatsunobe, STsuda, TSolitary pulmonary nodule: preliminary study of evaluation with incremental dynamic CTRadiology 1995 194 399CrossRef Google Scholar PubMed

Swensen, SJViggiano, RWMidthun, DELung nodule enhancement at CT: multicenter studyRadiology 2000 214 73CrossRef Google Scholar PubMed

Jeong, YJLee, KSJeong, SYSolitary pulmonary nodule: characterization with combined washin and washout features at dynamic multi-detector row CTRadiology 2005 237 675CrossRef Google Scholar

Yi, CALee, KSKim, B-TTissue characterization of solitary pulmonary nodule: comparative study between helical dynamic CT and integrated PET/CTJ Nucl Med 2006 47 443Google Scholar PubMed

Gould, MKSanders, GDBarnett, PGCost-effectiveness of alternative management strategies for patients with solitary pulmonary nodulesAnn Intern Med 2003 724CrossRef Google Scholar PubMed

Alberts, WMAmerican College of Chest Physicians. Diagnosis and management of lung cancer executive summary: ACCP evidence-based clinical practice guidelines (2nd Edition)Chest 2007 132 1SCrossRef Google Scholar

Fletcher, JWDjulbegovic, BSoares, HPRecommendations on the use of 18F-FDG PET in oncologyJ Nucl Med 2008 49 480CrossRef Google Scholar

Antoch, GStattaus, JNemat, ATNon-small cell lung cancer: dual-modality PET/CT in preoperative stagingRadiology 2003 229 526CrossRef Google Scholar PubMed

Dizendorf, EVBaumert, BGvon Schulthess, GKImpact of whole-body 18E-EDG PET on staging and managing patients for radiation therapyJ Nucl Med 2003 44 24Google Scholar PubMed

Ahuja, VColeman, REHerndon, JPatz, EFThe prognostic significance of fluorodeoxyglucose positron emission tomography imaging for patients with nonsmall cell lung carcinomaCancer 1998 83 9183.0.CO;2-Y>CrossRef Google Scholar PubMed

Cerfolio, RJBryant, ASOhja, BBartolucci, AA.The maximum standardized uptake values on positron emission tomography of a non-small cell lung cancer predict stage, recurrence, and survivalJ Thorac Cardiovasc Surg 2005 130 151CrossRef Google Scholar PubMed

Dillemans, BDeneffe, GVerschakelen, JDecramer, M.Value of computed tomography and mediastinoscopy in preoperative evaluation of mediastinal nodes in non-small cell lung cancer. A study of 569 patientsEur J Cardiothorac Surg 1994 8 37CrossRef Google Scholar PubMed

Toloza, EMHarpole, LMcCrory, DC.Noninvasive staging of non-small cell lung cancer: a review of the current evidenceChest 2003 123 137SCrossRef Google Scholar PubMed

Gould, MKKuschner, WGRydzak, CETest performance of positron emission tomography and computed tomography for mediastinal staging in patients with non-small-cell lung cancer: a meta-analysisAnn Intern Med 2003 139 879CrossRef Google Scholar PubMed

Gupta, NCGraeber, GMBishop, HA.Comparative efficacy of positron emission tomography with fluorodeoxyglucose in evaluation of small (< 1 cm), intermediate (1 to 3 cm), and large (> 3 cm) lymph node lesionsChest 2000 117 773CrossRef Google Scholar PubMed

de Langen, AJRaijmakers, PRiphagen, IPaul, MAHoekstra, OS.The size of mediastinal lymph nodes and its relation with metastatic involvement: a meta-analysisEur J Cardiothorac Surg 2006 29 26CrossRef Google Scholar PubMed

Vesselle, HTurcotte, ELinda, WHaynor, D.Application of a neural network to improve nodal staging accuracy with F-18 FDG PET in non-small cell lung cancerJ Nucl Med 2003 44 1918Google Scholar

Higashi, KIto, KHiramatsu, Y18F-FDG uptake by primary tumor as a predictor of intratumoral lymphatic vessel invasion and lymph node involvement in non-small cell lung cancer: analysis of a multicenter studyJ Nucl Med 2005 46 267Google Scholar PubMed

Quint, LETummala, SBrisson, LJDistribution of distant metastases from newly diagnosed non-small cell lung cancerAnn Thorac Surg 1996 62 246CrossRef Google Scholar PubMed

Sider, LHorejs, D.Frequency of extrathoracic metastases from bronchogenic carcinoma in patients with normal-sized hilar and mediastinal lymph nodes on CTAm J Roentgenol 1988 151 893CrossRef Google Scholar PubMed

Facey, KBradbury, ILaking, GPayne, E.Positron emission tomography (PET ) imaging in cancer management. Ultra Rapid Review. Health Technology AssessmentSouthamptonNHS R&D Programme 2004Google Scholar

Hellwig, DUkena, DPaulsen, FBamberg, MKirsch, CMOnko-PET der Deutschen Gesellschaft fur Nuklearmedizin. [Meta-analysis of the efficacy of positron emission tomography with F-18-fluorodeoxyglucose in lung tumors. Basis for discussion of the German Consensus Conference on PET in Oncology 2000]Pneumologie 2001 55 367CrossRef Google Scholar

Cook, GJHouston, SRubens, RMaisey, MNFogelman, I.Detection of bone metastases in breast cancer by 18FDG PET: differing metabolic activity in osteoblastic and osteolytic lesionsJ Clin Oncol 1998 16 3375CrossRef Google Scholar PubMed

Hustinx, RPaulus, PJacquet, NClinical evaluation of whole-body 18F-fluorodeoxyglucose positron emission tomography in the detection of liver metastasesAnn Oncol 1998 9 397CrossRef Google Scholar PubMed

MacManus, MPHicks, RJMatthews, JPHigh rate of detection of unsuspected distant metastases by PET in apparent stage III non-small-cell lung cancer: implications for radical radiation therapyInt J Radiat Oncol Biol Phys 2001 50 287CrossRef Google Scholar PubMed

Lardinois, DWeder, WRoudas, MEtiology of solitary extrapulmonary positron emission tomography and computed tomography findings in patients with lung cancerJ Clin Oncol 2005 23 6846CrossRef Google Scholar PubMed

Vansteenkiste, JFischer, BMDooms, CMortensen, J.Positron-emission tomography in prognostic and therapeutic assessment of lung cancer: systematic reviewLancet Oncol 2004 5 531CrossRef Google Scholar PubMed

de Geus-Oei, LFvan der Heijden, HFCorstens, FHOven, WJ.Predictive and prognostic value of FDG-PET in nonsmall-cell lung cancer: a systematic reviewCancer 2007 110 1654CrossRef Google Scholar PubMed

Weber, WAPetersen, VSchmidt, BPositron emission tomography in non-small-cell lung cancer: prediction of response to chemotherapy by quantitative assessment of glucose useJ Clin Oncol 2003 21 2651CrossRef Google Scholar PubMed

Cerfolio, RJBryant, ASWinokur, TSOhja, BBartolucci, AA.Repeat 18F-FDG-PET after neoadjuvant therapy is a predictor of pathologic response in patients with non-small cell lung cancerAnn Thorac Surg 2004 78 1903CrossRef Google Scholar

Inoue, TKim, EEKomaki, RDetecting recurrent or residual lung cancer with FDG-PETJ Nucl Med 1995 36 788Google Scholar PubMed

Patz, EFLowe, VJHoffman, JMPersistent or recurrent bronchogenic carcinoma: detection with PET and 2-[F-18]-2-deoxy-D-glucoseRadiology 1994 191 379CrossRef Google Scholar PubMed

Bury, TCorhay, JLDuysinx, BValue of FDG-PET in detecting residual or recurrent nonsmall cell lung cancerEur Respir J 1999 14 1376CrossRef Google Scholar PubMed

Hicks, RJKalff, VMacManus, MPThe utility of (18)F-FDG PET for suspected recurrent non-small cell lung cancer after potentially curative therapy: impact on management and prognostic stratificationJ Nucl Med 2001 42 1605Google Scholar PubMed

Higashi, KUeda, YArisaka, Y18F-FDG uptake as a biologic prognostic factor for recurrence in patients with surgically resected non-small cell lung cancerJ Nucl Med 2002 43 39Google Scholar PubMed

Singnurkar, ASolomon, SBGönen, MLarson, SMSchöder, H.18F-FDG PET/CT for the prediction and detection of local recurrence after radiofrequency ablation of malignant lung lesionsJ Nucl Med 2010 51 1833CrossRef Google Scholar PubMed

Shiono, SAbiko, MSato, T.Positron emission tomography/computed tomography and lymphovascular invasion predict recurrence in stage I lung cancersJ Thorac Oncol 2011 6 43CrossRef Google Scholar PubMed

Hellwig, DGröschel, AGraeter, TPDiagnostic performance and prognostic impact of FDG-PET in suspected recurrence of surgically treated non-small cell lung cancerEur J Nucl Med Mol Imaging 2006 33 13CrossRef Google Scholar PubMed

Schumacher, TBrink, IMix, MFDG-PET imaging for the staging and follow-up of small cell lung cancerEur J Nucl Med 2001 28 483CrossRef Google Scholar PubMed

Kamel, EMZwahlen, DWyss, MTWhole-body (18)F-FDG PET improves the management of patients with small cell lung cancerJ Nucl Med 2003 44 1911Google Scholar PubMed

Bradley, JDDehdashti, FMintun, MAPositron emission tomography in limited-stage small-cell lung cancer: a prospective studyJ Clin Oncol 2004 22 3248CrossRef Google Scholar PubMed

Shen, YYShiau, YCWang, JJHo, STKao, CH.Whole-body 18F-2-deoxyglucose positron emission tomography in primary staging small cell lung cancerAnticancer Res 2002 22 1257Google Scholar PubMed

Fischer, BMMortensen, JLanger, SWA prospective study of PET/CT in initial staging of small-cell lung cancer: comparison with CT, bone scintigraphy and bone marrow analysisAnn Oncol 2007 18 338CrossRef Google Scholar PubMed

Azad, AChionh, FScott, AMHigh impact of 18F-FDG-PET on management and prognostic stratiﬁcation of newly diagnosed small cell lung cancerMol Imaging Biol 2010 12 443CrossRef Google Scholar

Fischer, BMMortensen, JLanger, SWPET/CT imaging in response evaluation of patients with small cell lung cancerLung Cancer 2006 54 41CrossRef Google Scholar PubMed

Lee, YJCho, ACho, BCHigh tumor metabolic activity as measured by fluorodeoxyglucose positron emission tomography is associated with poor prognosis in limited and extensive stage small-cell lung cancerClin Cancer Res 2009 15 2426CrossRef Google Scholar PubMed

Connelly, RRSpirtas, RMyers, MHPercy, CLFraumeni, JFDemographic patterns for mesothelioma in the United StatesJ Natl Cancer Inst 1987 78 1053Google Scholar PubMed

Price, BWare, A.Time trend of mesothelioma incidence in the United States and projection of future cases: an update based on SEER data for 1973 through 2005Crit Rev Toxicol 2009 39 576CrossRef Google Scholar PubMed

Wagner, JCSleggs, CAMarchand, P.Diffuse pleural mesothelioma and asbestos exposure in the North Western Cape ProvinceBr J Ind Med 1960 17 260Google Scholar PubMed

Bianchi, CGiarelli, LGrandi, GLatency periods in asbestos-related mesothelioma of the pleuraEur J Cancer Prev 1997 6 162Google Scholar PubMed

Travis, WD.Sarcomatoid neoplasms of the lung and pleuraArch Pathol Lab Med 2010 134 1645Google Scholar PubMed

Lopez-Rios, FIllei, PBRusch, VLadanyi, M.Evidence against a role for SV40 infection in human mesotheliomas and high risk of false-positive PCR results owing to presence of SV40 sequences in common laboratory plasmidsLancet 2004 364 1157CrossRef Google Scholar PubMed

Manfredi, JJDong, JLiu, WJEvidence against a role for SV40 in human mesotheliomaCancer Res 2005 65 2602CrossRef Google Scholar PubMed

Klebe, SBrownlee, NAMahar, ASarcomatoid mesothelioma: a clinical-pathologic correlation of 326 casesMod Pathol 2010 23 470CrossRef Google Scholar PubMed

Gerbaudo, VHKatz, SNowak, AFrancis, R.Multimodality imaging review of malignant pleural mesothelioma diagnosis and stagingPET Clinics 2011 6 275CrossRef Google Scholar PubMed

Nowak, AFrancis, RKatz, SGerbaudo, VH.Multimodality imaging review of malignant pleural mesothelioma response to therapy assessmentPET Clinics 2011 6 299CrossRef Google Scholar

Metintas, MUcgun, IElbek, OComputed tomography features in malignant pleural mesothelioma and other commonly seen pleural diseasesEur J Radiol 2002 41 1CrossRef Google Scholar PubMed

Yamamuro, MGerbaudo, VHGill, RRMorphologic and functional imaging of malignant pleural mesotheliomaEur J Radiol 2007 64 356CrossRef Google Scholar PubMed

Gill, RRGerbaudo, VHJacobson, FLMR imaging of benign and malignant pleural diseaseMagn Reson Imaging Clin N Am 2008 16 319CrossRef Google Scholar PubMed

Bénard, FSterman, DSmith, RJMetabolic imaging of malignant pleural mesothelioma with fluorodeoxyglucose positron emission tomographyChest 1998 114 713CrossRef Google Scholar PubMed

Gerbaudo, VHSugarbaker, DJBritz-Cunningham, SAssessment of malignant pleural mesothelioma with 18 F-FDG dual-head gamma-camera coincidence imaging: comparison with histopathologyJ Nucl Med 2002 43 1144Google Scholar PubMed

Carretta, ALandoni, CMelloni, G18-FDG positron emission tomography in the evaluation of malignant pleural diseases – a pilot studyEur J Cardiothorac Surg 2000 17 377CrossRef Google Scholar PubMed

Bury, TPaulus, PDowlati, AEvaluation of pleural diseases with FDG-PET imaging: preliminary reportThorax 1997 52 187CrossRef Google Scholar PubMed

Schneider, DBClary-Macy, CChalla, SPositron emission tomography with F18-fluorodeoxyglucose in the staging and preoperative evaluation of malignant pleural mesotheliomaJ Thorac Cardiovasc Surg 2000 120 128CrossRef Google Scholar PubMed

Sugarbaker, DJFlores, RMJaklitsch, MTResection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patientsJ Thorac Cardiovasc Surg 1999 117 54CrossRef Google Scholar PubMed

Rusch, VW.A proposed new international TNM staging system for malignant pleural mesothelioma from the International Mesothelioma Interest GroupLung Cancer 1996 14 1CrossRef Google Scholar PubMed

Flores, RMAkhurst, TGonen, MLarson, SMRusch, VW.Positron emission tomography defines metastatic disease but not locoregional disease in patients with malignant pleural mesotheliomaJ Thorac Cardiovasc Surg 2003 126 11CrossRef Google Scholar

Erasmus, JJTruong, MTSmythe, WRIntegrated computed tomography-positron emission tomography in patients with potentially resectable malignant pleural mesothelioma: Staging implicationsJ Thorac Cardiovasc Surg 2005 129 1364CrossRef Google Scholar PubMed

Gerbaudo, VH.18F-FDG imaging of malignant pleural mesothelioma: scientiam impendere vero. . . [Editorial]Nucl Med Com 2003 24 609CrossRef Google Scholar

Baldini, EHRecht, AStrauss, GMPatterns of failure after trimodality therapy for malignant pleural mesotheliomaAnn Thorac Surg 1997 63 334Google Scholar PubMed

Oksuzoglu, BYalcin, SErman, MDagdelen, S.Leptomeningeal infiltration of malignant mesotheliomaMed Oncol 2002 19 167CrossRef Google Scholar PubMed

Gerbaudo, VHMamede, MTrotman-Dickenson, BHatabu, HSugarbaker, DJ.FDG PET/CT patterns of treatment failure of malignant pleural mesothelioma: relationship to histologic type, treatment algorithm, and survivalEur J Nucl Med Mol Imaging 2011 38 810CrossRef Google Scholar

Baldini, EHRecht, AStrauss, GMPatterns of failure after trimodality therapy for malignant pleural mesotheliomaAnn Thorac Surg 1997 63 334Google Scholar PubMed

Jänne, PABaldini, EH.Patterns of failure following surgical resection for malignant pleural mesotheliomaThorac Surg Clin 2004 14 567CrossRef Google Scholar PubMed

Book contents

Chapter 7 - Lung and pleura

Summary

Access options

References

Save book to Kindle

Save book to Dropbox

Save book to Google Drive